{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T18:48:59Z","timestamp":1792349339258,"version":"4.4.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T00:00:00Z","timestamp":1792281600000},"content-version":"vor","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,7]]},"abstract":"<jats:title>abstract<\/jats:title>\n                  <jats:p>An ultra-performance liquid chromatography (UPLC) technique with photodiode array-mass spectrometry (PDA-MS) detectors has been developed and validated for the determination of glycopyrronium bromide (GB), formoterol fumarate dihydrate (FFD) and their related substances in pressurized meter dose inhalers. This marks the first time the method has been implemented. Chromatographic analyses have been carried out on a UPLC system with a single quadrupole mass spectrometer (QDa) and a PDA detector. A C18 column has been used prior to the injection valve. The column temperature was set to 40\u00b0C. For each analysis, 1 \u03bcL of sample was injected at a flow rate of 0.1 mL\/minute. The mobile phases used were A (0.5% formic acid in methanol) and B (0.5% formic acid in water). The total run time of the method was 30 minutes. The PDA detector was employed at 215 nm while the mass detector was set to extracted ion chromatography (XIC) mode. The range for detecting impurities of GB was found to be between 0.28 and 0.30 ng\/mL, with a limits of 0.92\u20131.01 ng\/mL for quantification. GB and FFD demonstrated linear accuracy. We studied the accuracy of related substances within the limit of quantification value range of corresponding impurities and up to 400% of the limit value. The method we used was linear, rapid, reproducible and accurate. Our proposed method is fast, linear, accurate and reproducible. The UPLC-MS method, which utilized QDa with XIC mode, was developed to ascertain the related substances and assay of GB and FFD.<\/jats:p>","DOI":"10.1093\/chromsci\/bmag030","type":"journal-article","created":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T17:59:47Z","timestamp":1792346387000},"source":"Crossref","is-referenced-by-count":0,"title":["Glycopyrronium bromide, formoterol fumarate dihydrate and their related compounds with UPLC\/PDA-MS for simultaneous determination in pressurized metered-dose inhaler product"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3932-390X","authenticated-orcid":false,"given":"Serdar","family":"Seckin","sequence":"first","affiliation":[{"name":"Analytical Chemistry, Institute of Health Sciences, Istanbul University , 34126, Beyaz\u0131t, Istanbul ,","place":["T\u00fcrkiye"]},{"name":"DEVA Holding A.S., R&D Center , Karaa\u011fa\u00e7 Mh. Fatih Blv. No: 26, Kapakl\u0131, 59510, Tekirda\u011f ,","place":["T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0906-218X","authenticated-orcid":false,"given":"Serap Saglik","family":"Aslan","sequence":"additional","affiliation":[{"name":"Department of Analytical Chemistry, Faculty of Pharmacy, Istanbul University , Beyaz\u0131t, 34116, Istanbul ,","place":["T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,18]]},"reference":[{"key":"2026101813593998600_ref1"},{"issue":"11","key":"2026101813593998600_ref2","doi-asserted-by":"publisher","first-page":"e442","DOI":"10.1371\/journal.pmed.0030442","article-title":"Projections of global mortality and burden of disease from 2002 to 2030","volume":"3","author":"Mathers","year":"2006","journal-title":"PLoS Medicine"},{"key":"2026101813593998600_ref3","doi-asserted-by":"publisher","volume-title":"Global Problems, Local Solutions: Costs and Benefits.","DOI":"10.1017\/CBO9781139600484"},{"issue":"4","key":"2026101813593998600_ref4","doi-asserted-by":"publisher","DOI":"10.5005\/jp\/books\/12063_1","volume":"187","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"2026101813593998600_ref5","volume-title":"Robbins and Cotran pathologic basis of disease","author":"Kumar","year":"2015","edition":"9"},{"key":"2026101813593998600_ref6"},{"issue":"9823","key":"2026101813593998600_ref7","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/S0140-6736(11)60968-9","article-title":"Chronic obstructive pulmonary disease","volume":"379","author":"Decramer","year":"2012","journal-title":"Lancet"},{"key":"2026101813593998600_ref8","volume-title":"Murray and Nadel\u2019s textbook of respiratory medicine","author":"Mason","year":"2010","edition":"5"},{"issue":"6","key":"2026101813593998600_ref9","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1164\/rccm.200703-456SO","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary","volume":"176","author":"Rabe","year":"2007","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"1","key":"2026101813593998600_ref10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/1465-9921-8-89","article-title":"COPD diagnosis related to different guidelines and spirometry techniques","volume":"8","author":"Nathell","year":"2007","journal-title":"Respiratory Research"},{"key":"2026101813593998600_ref11"},{"key":"2026101813593998600_ref12","volume-title":"European Pharmacopoeia"},{"key":"2026101813593998600_ref13","volume-title":"European Pharmacopoeia"},{"key":"2026101813593998600_ref14","volume":"588","journal-title":"International Journal of Pharmaceutics"},{"issue":"5","key":"2026101813593998600_ref15","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/S0731-7085(03)00425-4","article-title":"Validation of a RP-HPLC method for assay of formoterol and its related substances in formoterol fumarate dihydrate drug substance","volume":"33","author":"Akapo","year":"2003","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"issue":"1","key":"2026101813593998600_ref16","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.bfopcu.2016.02.001","article-title":"Validated chromatographic methods for the simultaneous determination of mometasone furoate and formoterol fumarate dihydrate in a combined dosage form","volume":"54","author":"Merey","year":"2016","journal-title":"Bulletin of Faculty of Pharmacy, Cairo University."},{"key":"2026101813593998600_ref17","doi-asserted-by":"publisher","volume":"9","journal-title":"Arabian Journal of Chemistry","DOI":"10.1016\/j.arabjc.2015.05.005"},{"key":"2026101813593998600_ref18","doi-asserted-by":"publisher","volume":"193","journal-title":"Journal of Pharmaceutical and Biomedical Analysis","DOI":"10.1016\/j.jpba.2020.113729"},{"key":"2026101813593998600_ref19","doi-asserted-by":"publisher","volume":"80","journal-title":"Scientia Pharmaceutica","DOI":"10.3797\/scipharm.1204-06"},{"issue":"2","key":"2026101813593998600_ref20","first-page":"219","article-title":"Stability indicating HPLC method for simultaneous estimation of mometasone furoate and formoterol fumarate in combined dosage form","volume":"5","author":"Gujarati","year":"2014","journal-title":"Pharmacophore"},{"key":"2026101813593998600_ref21","doi-asserted-by":"publisher","volume":"204","journal-title":"Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy","DOI":"10.1016\/j.saa.2018.06.078"},{"key":"2026101813593998600_ref22","doi-asserted-by":"publisher","volume":"889\u2013890","journal-title":"Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences","DOI":"10.1016\/j.jchromb.2012.02.008"},{"issue":"1","key":"2026101813593998600_ref23","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jchromb.2008.10.013","article-title":"Quantitative determination of glycopyrrolate in human plasma by liquid chromatography\u2013electrospray ionization mass spectrometry: the use of a volatile ion-pairing agent during both liquid\u2013liquid extraction and liquid chromatography","volume":"876","author":"Storme","year":"2008","journal-title":"Journal of Chromatography B"},{"issue":"4","key":"2026101813593998600_ref24","doi-asserted-by":"publisher","first-page":"s47","DOI":"10.5530\/ijper.52.4s.75","article-title":"Synchronous estimation of glycopyrrolate and formoterol in bulk and pharmaceutical dosage form by RP-HPLC method","volume":"52","author":"Erukulla","year":"2018","journal-title":"Indian Journal of Pharmaceutical Education and Research."},{"key":"2026101813593998600_ref25","volume-title":"PhD diss., \u0130stanbul University, Institute of Health Sciences, Department of Analytical Chemistry"},{"key":"2026101813593998600_ref26"}],"container-title":["Journal of Chromatographic Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/chromsci\/article-pdf\/64\/9\/bmag030\/72077516\/bmag030.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/chromsci\/article-pdf\/64\/9\/bmag030\/72077516\/bmag030.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T17:59:48Z","timestamp":1792346388000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/chromsci\/article\/doi\/10.1093\/chromsci\/bmag030\/8935399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,10,7]]}},"URL":"https:\/\/doi.org\/10.1093\/chromsci\/bmag030","relation":{},"ISSN":["0021-9665","1945-239X"],"issn-type":[{"value":"0021-9665","type":"print"},{"value":"1945-239X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,10]]},"article-number":"bmag030"}}